NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence

Rhea-AI Summary

NEXGEL (NASDAQ:NXGL) announced financing of $1.797 million related to a potential acquisition targeted to close in the first quarter of 2026. The transaction is subject to mutual due diligence and other conditions, and funds will be returned to the investor if the acquisition is not consummated. The investor may provide a potential additional $14.869 million pending completion of full due diligence. Palladium Capital Group acted as placement agent. The company said it will provide further details to shareholders during Q1 2026.

Positive

• Committed financing of $1.797 million
• Potential follow-on investment of $14.869 million
• Acquisition targeted to close in Q1 2026

Negative

• Transaction subject to mutual due diligence and other conditions
• Funds refundable to investor if transaction is not consummated

News Market Reaction – NXGLW

%

1 alert

% News Effect

On the day this news was published, NXGLW declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the financing of $1.797 million relating to a potential acquisition targeted for the first quarter of 2026. The potential acquisition is subject to the completion of due diligence by both NEXGEL and the investor. The funds will be returned to the investor should the transaction not be consummated.

“After successfully closing and integrating several acquisitions over the last several years, we have continued to evaluate other potential accretive transactions,” said Adam Levy, CEO of NEXGEL. “We have identified assets to acquire with an up-front commitment from an investor in the amount of $1.797 million and a potential additional investment of $14.869 million relating to the acquisition, pending the completion of full due diligence by both parties and subject to other conditions. We expect to provide shareholders with further information on the acquisition during the first quarter of 2026.”

Palladium Capital Group, LLC acted as the placement agent on the transaction.

The financing transaction is more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 10, 2026.

About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “potential,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “lends,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts, including, without limitation, our ability to consummate the potential acquisition and the related additional investment. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2024, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com

FAQ

What financing did NEXGEL (NXGL) announce on February 10, 2026?

NEXGEL announced financing of $1.797 million tied to a potential acquisition. According to the company, the financing is for a targeted Q1 2026 acquisition and may include a potential additional $14.869 million pending due diligence.

When does NEXGEL expect the acquisition related to the NXGL financing to close?

NEXGEL expects the acquisition to target closing in the first quarter of 2026. According to the company, completion remains subject to mutual due diligence and other customary conditions before closing can occur.

Is the $1.797 million financing for NXGL refundable if the acquisition falls through?

Yes, the funds will be returned to the investor if the transaction is not consummated. According to the company, the financing is conditional and refundable pending completion of due diligence by both parties.

Who acted as placement agent for NEXGEL's February 10, 2026 financing?

Palladium Capital Group served as the placement agent on the transaction. According to the company, Palladium Capital Group, LLC facilitated the placement related to the potential acquisition financing.

How large could the total investor commitment be for the NXGL acquisition?

The initial commitment is $1.797 million with a potential additional $14.869 million. According to the company, the larger commitment depends on completion of full due diligence and satisfaction of other conditions.